Injection under the skin (subcutaneous)
Moderate to severe Crohn’s disease and ulcerative colitis
Recommendations for Pregnancy
Recommendations for Lactation
Limited human data: probably compatible
Reduces signs and symptoms and induces and maintains clinical response in adults and children with moderately to severely active Crohn’s disease and ulcerative colitis who have had an inadequate response to conventional therapy.
Indicated for pediatric use
Most common side effects
Common side-effects include injection site reactions such as redness, rash, swelling, itching, pain, or bruising; upper respiratory infections (including sinus infections); headaches, rash, nausea. Rare side effects include lupus-like syndrome.
There have been reports of serious infections associated with adalimumab, including tuberculosis (TB) and other infections such as viruses, fungi, and other bacteria that have spread throughout the body. On rare occasions certain types of cancer, including lymphoma, have been reported.
To see the full prescribing information for this medication, click here.
Scroll right by clicking & dragging with your cursor or swiping with your finger.